These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 9776715)

  • 21. Antinucleolar autoantibodies demonstrated by monolayers of human fibroblasts in sera from patients with systemic lupus erythematosus, progressive systemic sclerosis and chronic active hepatitis.
    Kenneally D; Mackay IR; Toh BH
    J Clin Lab Immunol; 1984 May; 14(1):13-6. PubMed ID: 6748043
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunogenicity of DNA modified by singlet oxygen: implications in systemic lupus erythematosus and cancer.
    Khan F; Khan F; Ali R
    Biotechnol Appl Biochem; 2007 Feb; 46(Pt 2):97-103. PubMed ID: 16939412
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Profiles of antibodies to poly(ADP-ribose), left-handed Z-DNA, and other nuclear constituents in systemic lupus erythematosus and progressive systemic sclerosis.
    Kanai Y; Moroi Y; Yokohari R; Goto S
    Princess Takamatsu Symp; 1983; 13():93-100. PubMed ID: 6654833
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. II. Reactivity with hsa-coupled, uridine-containing, monophosphoric ribodinucleotides.
    Alarcón-Segovia D; Fishbein E; Estrada-Parra S; García-Ortigoza E
    Immunology; 1976 Mar; 30(3):413-8. PubMed ID: 1082854
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Polynucleotide specificity of anti-reactive oxygen species (ROS) DNA antibodies.
    Ara J; Ali R
    Clin Exp Immunol; 1993 Oct; 94(1):134-9. PubMed ID: 8403495
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hydroxyl radical damaged immunoglobulin G in patients with rheumatoid arthritis: biochemical and immunological studies.
    Rasheed Z
    Clin Biochem; 2008 Jun; 41(9):663-9. PubMed ID: 18359293
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Enhanced reactivity to malondialdehyde-modified proteins by systemic lupus erythematosus autoantibodies.
    Ben Mansour R; Lassoued S; Elgaied A; Haddouk S; Marzouk S; Bahloul Z; Masmoudi H; Attia H; Aïfa MS; Fakhfakh F
    Scand J Rheumatol; 2010 May; 39(3):247-53. PubMed ID: 20429675
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization of chromatin modified with reactive oxygen species: recognition by autoantibodies in cancer.
    Mansoor F; Ali R
    Clin Biochem; 2007 Sep; 40(13-14):928-35. PubMed ID: 17628516
    [TBL] [Abstract][Full Text] [Related]  

  • 29. OxLDL/beta2GPI complexes and autoantibodies in patients with systemic lupus erythematosus, systemic sclerosis, and antiphospholipid syndrome: pathogenic implications for vascular involvement.
    Lopez LR; Simpson DF; Hurley BL; Matsuura E
    Ann N Y Acad Sci; 2005 Jun; 1051():313-22. PubMed ID: 16126973
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Induction of endothelial cell apoptosis by heat-shock protein 60-reactive antibodies from anti-endothelial cell autoantibody-positive systemic lupus erythematosus patients.
    Dieudé M; Senécal JL; Raymond Y
    Arthritis Rheum; 2004 Oct; 50(10):3221-31. PubMed ID: 15476243
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Naturally occurring and disease-associated auto-antibodies against topoisomerase I: a fine epitope mapping study in systemic sclerosis and systemic lupus erythematosus.
    Simon D; Czömpöly T; Berki T; Minier T; Peti A; Tóth E; Czirják L; Németh P
    Int Immunol; 2009 Apr; 21(4):415-22. PubMed ID: 19211583
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Studies on peroxynitrite-modified H1 histone: implications in systemic lupus erythematosus.
    Khan MA; Dixit K; Moinuddin ; Arif Z; Alam K
    Biochimie; 2014 Feb; 97():104-13. PubMed ID: 24113317
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Antibodies to poly (adenosine diphosphate-ribose) in systemic lupus erythematosus and drug induced lupus].
    Matsuzaki M; Tsukada Y; Kayahara H; Tadasa K; Ina K
    Arerugi; 1992 Mar; 41(3):447-53. PubMed ID: 1575642
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Evaluation of antibodies to thymine ROS-modified DNA poly(dT), in patients with immunologic disorders: relationships to anti n-DNA and anti ENA autoantibodies.
    Brusca I; Li Vigni P; Sucato R; Cilluffo N; La Chiusa SM
    Panminerva Med; 2002 Mar; 44(1):33-5. PubMed ID: 11887089
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Autoantibodies against granulocyte colony-stimulating factor in Felty's syndrome and neutropenic systemic lupus erythematosus.
    Hellmich B; Csernok E; Schatz H; Gross WL; Schnabel A
    Arthritis Rheum; 2002 Sep; 46(9):2384-91. PubMed ID: 12355486
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Immunochemical characterization of the anti-RNA antibodies found in scleroderma and systemic lupus erythematosus. I. Differences in reactivity with Poly (U) and Poly-(A) Poly (U).
    Alarcón-Segovia D; Fishbein E
    J Immunol; 1975 Jul; 115(1):28-31. PubMed ID: 50353
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Rabbit anti-HMG-17 antibodies recognize similar epitopes on the HMG-17 molecule as lupus autoantibodies. Relation with histone H1 defined epitopes.
    Boumba VA; Seferiadis K
    J Pept Sci; 2002 Dec; 8(12):683-94. PubMed ID: 12523645
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Induction of systemic lupus erythematosus-like syndrome in syngeneic mice by immunization with activated lymphocyte-derived DNA.
    Qiao B; Wu J; Chu YW; Wang Y; Wang DP; Wu HS; Xiong SD
    Rheumatology (Oxford); 2005 Sep; 44(9):1108-14. PubMed ID: 15840592
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Autoantibodies in SLE but not in scleroderma react with protein-stripped nucleosomes.
    Suer W; Dähnrich C; Schlumberger W; Stöcker W
    J Autoimmun; 2004 Jun; 22(4):325-34. PubMed ID: 15120756
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Decreased levels of autoantibody against histone deacetylase 3 in patients with systemic sclerosis.
    Kuwatsuka Y; Ogawa F; Iwata Y; Komura K; Muroi E; Hara T; Takenaka M; Shimizu K; Hasegawa M; Fujimoto M; Sato S
    Autoimmunity; 2009 Feb; 42(2):120-5. PubMed ID: 19021012
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.